{{Rsnum
|rsid=1861647
|Gene=SLC6A2
|Chromosome=16
|position=55694494
|Orientation=plus
|GMAF=0.2769
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC6A2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 13.8 | 60.0 | 26.2
| HCB | 6.7 | 40.0 | 53.3
| JPT | 2.3 | 40.9 | 56.8
| YRI | 1.6 | 17.5 | 81.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 40.0 | 53.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19727679
|Title=Further evidence of association between amphetamine response and SLC6A2 gene variants
}} (Associated with [[ADHD]].)

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}